Standardizing Reporting of Glucose and Insulin Data for Patients on Multiple Daily Injections Using Connected Insulin Pens and Continuous Glucose Monitoring

被引:9
|
作者
Rodbard, David [1 ]
Garg, Satish K. [2 ,3 ]
机构
[1] Biomed Informat Consultants LLC, Clin Biostat Dept, 10113 Bentcross Dr, Potomac, MD 20854 USA
[2] Univ Colorado, Dept Med, Barbara Davis Ctr Diabet, Anschutz Med Campus, Aurora, CO USA
[3] Univ Colorado, Dept Pediat, Barbara Davis Ctr Diabet, Anschutz Med Campus, Aurora, CO USA
关键词
Continuous glucose monitoring; Connected insulin pens; Multiple daily injections; Diabetes mellitus; Ambulatory glucose profile; Insulin dosage calculators; BLOOD-GLUCOSE; GLYCEMIC CONTROL; DIABETES CARE; PROFILE; TECHNOLOGY; CONSENSUS;
D O I
10.1089/dia.2021.0030
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Recent development and availability of several connected insulin pens with digital memory are likely to expand the availability of glucose and insulin metrics that previously had been available only for the much smaller number of people using insulin pumps. It would be highly desirable to standardize data presentations to avoid the chaotic emergence of multiple formats that might reduce the clinical utility of connected pens. Methods: We reviewed the literature and analyzed data displays from multiple blood glucose monitoring, continuous glucose monitoring (CGM), insulin pump, and automated insulin delivery systems, and methods for combination of glucose and insulin data. We examined multiple forms of presentation and now propose a prototype for a standardized method for data analysis and display, focusing on the content and format of a one-page dashboard summary for patients on multiple daily injection (MDI) insulin regimens. Results: We propose the following metrics to be included in the one-page report: (A) glucose metrics: simplified glucose distribution in the form of a stacked bar chart showing percentages of time below-, above-, or within-target ranges overall and (optionally) by date, by time of day, or day of the week; (B) insulin metrics: types and doses, and timing of basal and bolus insulin; (C) an enhanced ambulatory glucose profile or "AGP+" showing glucose data points and/or distributions (10th to 90th percentiles), dosages and timing of basal and bolus insulins and (optionally) graphical display of risk of hypoglycemia and hyperglycemia; and (D) user experience regarding technology usage, frequency of alerts for hypo- and hyperglycemia, and information regarding lifestyle, meals, exercise, and sleep, if available; and (E) clinical insights and interpretation. Conclusion: We propose a prototype for a dashboard summary report of glucose, insulin, meals, and activity data intended for providers and patients on MDI using connected pens and CGM. Our goal is to stimulate development of a standardized approach.
引用
收藏
页码:221 / 226
页数:6
相关论文
共 50 条
  • [1] Acceptability of Continuous Glucose Monitoring in Elderly Diabetes Patients Using Multiple Daily Insulin Injections
    Volcansek, Spela
    Lunder, Mojca
    Janez, Andrej
    [J]. DIABETES TECHNOLOGY & THERAPEUTICS, 2019, 21 (10) : 566 - 574
  • [2] Effect of Continuous Glucose Monitoring on Glycemic Control in Adults Using Multiple Daily Insulin Injections
    Price, David A.
    Riddlesworth, Tonya
    Beck, Roy W.
    Wolpert, Howard A.
    Bergenstal, Richard M.
    Ahmann, Andrew J.
    [J]. DIABETES, 2017, 66 : A17 - A17
  • [3] Continuous glucose monitoring for patients with type 1 diabetes on multiple daily injections of insulin: pros and cons
    Maiorino, Maria Ida
    Petrizzo, Michela
    Bellastella, Giuseppe
    Esposito, Katherine
    [J]. ENDOCRINE, 2018, 59 (01) : 62 - 65
  • [4] Continuous glucose monitoring for patients with type 1 diabetes on multiple daily injections of insulin: pros and cons
    Maria Ida Maiorino
    Michela Petrizzo
    Giuseppe Bellastella
    Katherine Esposito
    [J]. Endocrine, 2018, 59 : 62 - 65
  • [5] Continuous Glucose Monitoring (CGM) reduces glucose variability and improves glycaemic control in patients using Multiple Daily Injections (MDI) or insulin pumps
    Rodbard, D.
    Garg, S.
    Jovanovic, L.
    [J]. DIABETOLOGIA, 2009, 52 : S364 - S365
  • [6] A qualitative comparison between multiple daily injections and continuous subcutaneous insulin infusion using a continuous glucose monitoring system
    Javor, ED
    Ilic, S
    Lee, SW
    [J]. DIABETES, 2001, 50 : A438 - A438
  • [7] Continuous Glucose Monitoring in Patients With Type 1 Diabetes Using Insulin Injections
    Foster, Nicole C.
    Miller, Kellee M.
    Tamborlane, William V.
    Bergenstal, Richard M.
    Beck, Roy W.
    [J]. DIABETES CARE, 2016, 39 (06) : E81 - E82
  • [8] Responses to Continuous Glucose Monitoring in Subjects with Type 1 Diabetes Using Continuous Subcutaneous Insulin Infusion or Multiple Daily Injections
    Rodbard, David
    Jovanovic, Lois
    Garg, Satish K.
    [J]. DIABETES TECHNOLOGY & THERAPEUTICS, 2009, 11 (12) : 757 - 765
  • [9] Continuous Glucose Monitoring Versus Usual Care in Patients With Type 2 Diabetes Receiving Multiple Daily Insulin Injections
    Haak, Thomas
    [J]. ANNALS OF INTERNAL MEDICINE, 2018, 168 (07) : 525 - 526
  • [10] Comment on "The pros and cons of continuous glucose monitoring for patients with type 1 diabetes on multiple daily injections of insulin."
    Giulio, Frontino
    Valeria, Favalli
    Clara, Bonura
    [J]. ENDOCRINE, 2018, 59 (01) : 230 - 230